Can Biosimilars Be The Next Growth Driver For Pfizer?

Biosimilars are versions of biologic medicines that have been developed and proven to be highly similar to the original biologic. They usually offer high-quality, lower-cost alternatives to biologic medicines. Pfizer (NYSE:PFE) has been focused on developing biosimilars of late. In fact, it has ...